Rapid Dose Therapeutics and McMaster University’s COVID-19 Vaccine Study Receives NSERC Research and Development Grant
Ryan Allway December 22nd, 2021 Uncategorized BURLINGTON, Ontario, December 22, 2021–(BUSINESS WIRE)–Today, Rapid Dose Therapeutics Corp. (“RDT” or the “Company“) (CSE: DOSE) and McMaster University (“McMaster“) are pleased to announce that the ongoing development of an orally delivered vaccine candidate for COVID-19 has received the final installment of the... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )